China Healthwise Holdings Limited, commonly referred to as Healthwise, is a prominent player in the healthcare industry, headquartered in Hong Kong (HK). Founded in 2000, the company has established itself as a leader in the development and distribution of innovative healthcare products and services across Asia. Healthwise focuses on a diverse range of sectors, including pharmaceuticals, health supplements, and medical devices. Its core offerings are distinguished by their commitment to quality and efficacy, catering to the growing demand for health-conscious solutions. The company has achieved significant milestones, including strategic partnerships and expansions that enhance its market presence. With a strong reputation for reliability and innovation, China Healthwise Holdings Limited continues to solidify its position in the competitive healthcare landscape, making strides towards improving health outcomes for consumers across the region.
How does China Healthwise Holdings Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Recreation and Sports Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
China Healthwise Holdings Limited's score of 19 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, China Healthwise Holdings Limited reported carbon emissions of approximately 119,000 kg CO2e, all of which fall under Scope 2 emissions. This follows a total of about 122,000 kg CO2e in 2023, also entirely from Scope 2 emissions. The company has shown a consistent commitment to monitoring its carbon footprint, with emissions data available for the past few years, including 143,000 kg CO2e in 2022 and 137,000 kg CO2e in 2021. Despite these figures, China Healthwise Holdings Limited has not set specific reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). The absence of Scope 1 and Scope 3 emissions data indicates a potential area for improvement in their overall emissions reporting and climate strategy. The company operates from its headquarters in Hong Kong and has not inherited emissions data from any parent organisation, indicating that its reported figures are solely its own. As the global focus on climate action intensifies, China Healthwise Holdings Limited may benefit from establishing clear reduction targets and engaging in broader sustainability initiatives to enhance its environmental performance.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2023 | 2024 | |
---|---|---|---|---|
Scope 1 | - | - | - | - |
Scope 2 | 128,000 | 000,000 | 000,000 | 000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China Healthwise Holdings Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.